Crossmark

RIPK3 and kidney disease

Crossref DOI link: https://doi.org/10.1016/j.nefroe.2023.04.006

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Guerrero-Mauvecin, Juan

Fontecha-Barriuso, Miguel

López-Diaz, Ana M.

Ortiz, Alberto

Sanz, Ana B.
Funding

Funding for this research was provided by:

Sociedad Española de Nefrología

Sociedad Madrileña de Nefrología

European Commission

Federación Española de Enfermedades Raras (AC18/00064, DTS18/00032, ERA-PerMed-JTC2018, ISCIII-RETIC REDinREN RD016/0009, PERSTIGAN AC18/00071, PI19/00588, PI19/00815, PI22/00050, PI22/00469)

Instituto de Salud Carlos III (RD21/0005/0001)
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2023-04-29
More Information

This article is maintained by: Elsevier

Article Title: RIPK3 and kidney disease

Journal Title: Nefrología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefroe.2023.04.006

Content Type: article

Copyright: © 2022 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.